Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20868679rdf:typepubmed:Citationlld:pubmed
pubmed-article:20868679lifeskim:mentionsumls-concept:C0678804lld:lifeskim
pubmed-article:20868679lifeskim:mentionsumls-concept:C1858460lld:lifeskim
pubmed-article:20868679lifeskim:mentionsumls-concept:C1419285lld:lifeskim
pubmed-article:20868679lifeskim:mentionsumls-concept:C0348026lld:lifeskim
pubmed-article:20868679lifeskim:mentionsumls-concept:C1519249lld:lifeskim
pubmed-article:20868679lifeskim:mentionsumls-concept:C1261552lld:lifeskim
pubmed-article:20868679pubmed:issue3lld:pubmed
pubmed-article:20868679pubmed:dateCreated2010-11-15lld:pubmed
pubmed-article:20868679pubmed:abstractTextWe determined the feasibility of universal fetal marker detection in maternal circulation. Using real-time PCR, we compared the levels of fetal (SRY and hypermethylated RASSF1A) and total (GLO gene and total RASSF1A) extracellular DNA and fractions of extracellular fetal DNA (SRY/GLO vs. hypermethylated RASSF1A/total RASSF1A) in maternal circulation. Sensitivity and specificity reached 100% as the fetal-specific hypermethylated RASSF1A sequence was detected in all 151 examined plasma samples derived from 70 normal pregnancies with a singleton male (n=51) or female (n=19) fetus sampled throughout gestation and absent in non-pregnant individuals (n=29). A strong positive correlation was observed between fetal-derived hypermethylated RASSF1A and SRY (?=0.66, P<0.001), total RASSF1A and GLO (?=0.65,P<0.001), SRY/GLO vs. hypermethylated RASSF1A/total RASSF1A ratio (?=0.62, P<0.001) in maternal plasma. The results indicate that a universal fetal marker could be useful not only for the confirmation of the presence of fetal cell-free DNA in maternal plasma but could enable quantification of cell-free fetal DNA in pregnancy associated disorders, independently of the sex of the fetus.lld:pubmed
pubmed-article:20868679pubmed:languageenglld:pubmed
pubmed-article:20868679pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20868679pubmed:citationSubsetIMlld:pubmed
pubmed-article:20868679pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20868679pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20868679pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20868679pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20868679pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20868679pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20868679pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20868679pubmed:statusMEDLINElld:pubmed
pubmed-article:20868679pubmed:monthDeclld:pubmed
pubmed-article:20868679pubmed:issn1096-0945lld:pubmed
pubmed-article:20868679pubmed:authorpubmed-author:DouchaJJlld:pubmed
pubmed-article:20868679pubmed:authorpubmed-author:HromadnikovaI...lld:pubmed
pubmed-article:20868679pubmed:authorpubmed-author:ZejskovaLLlld:pubmed
pubmed-article:20868679pubmed:authorpubmed-author:JancuskovaTTlld:pubmed
pubmed-article:20868679pubmed:authorpubmed-author:KotlabovaKKlld:pubmed
pubmed-article:20868679pubmed:copyrightInfoCopyright © 2010 Elsevier Inc. All rights reserved.lld:pubmed
pubmed-article:20868679pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20868679pubmed:volume89lld:pubmed
pubmed-article:20868679pubmed:ownerNLMlld:pubmed
pubmed-article:20868679pubmed:authorsCompleteYlld:pubmed
pubmed-article:20868679pubmed:pagination241-7lld:pubmed
pubmed-article:20868679pubmed:meshHeadingpubmed-meshheading:20868679...lld:pubmed
pubmed-article:20868679pubmed:meshHeadingpubmed-meshheading:20868679...lld:pubmed
pubmed-article:20868679pubmed:meshHeadingpubmed-meshheading:20868679...lld:pubmed
pubmed-article:20868679pubmed:meshHeadingpubmed-meshheading:20868679...lld:pubmed
pubmed-article:20868679pubmed:meshHeadingpubmed-meshheading:20868679...lld:pubmed
pubmed-article:20868679pubmed:meshHeadingpubmed-meshheading:20868679...lld:pubmed
pubmed-article:20868679pubmed:meshHeadingpubmed-meshheading:20868679...lld:pubmed
pubmed-article:20868679pubmed:meshHeadingpubmed-meshheading:20868679...lld:pubmed
pubmed-article:20868679pubmed:meshHeadingpubmed-meshheading:20868679...lld:pubmed
pubmed-article:20868679pubmed:meshHeadingpubmed-meshheading:20868679...lld:pubmed
pubmed-article:20868679pubmed:meshHeadingpubmed-meshheading:20868679...lld:pubmed
pubmed-article:20868679pubmed:meshHeadingpubmed-meshheading:20868679...lld:pubmed
pubmed-article:20868679pubmed:meshHeadingpubmed-meshheading:20868679...lld:pubmed
pubmed-article:20868679pubmed:meshHeadingpubmed-meshheading:20868679...lld:pubmed
pubmed-article:20868679pubmed:year2010lld:pubmed
pubmed-article:20868679pubmed:articleTitleFeasibility of fetal-derived hypermethylated RASSF1A sequence quantification in maternal plasma--next step toward reliable non-invasive prenatal diagnostics.lld:pubmed
pubmed-article:20868679pubmed:affiliationDepartment of Molecular Biology and Cell Pathology, Third Faculty of Medicine, Charles University, Ruska 87, 100 00 Prague, Czech Republic. lenka.zej@centrum.czlld:pubmed
pubmed-article:20868679pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20868679pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed